Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype

17 Jun 2019

Abstract excerpt

BACKGROUND: Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT ≥ 3.5 mm. However, there is no current global consensus on the cutoff value for CMA. In this study, we aimed to discuss the fetuses with smaller increased NT which was between cutoff value...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomic variations and chromosomal abnormalities
Share to Gestational Trophoblastic Disease Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31209990
DOI: 10.1002/mgg3.811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotypePMID 31209990Read ↗

Application of chromosomal microarray in fetuses with increased nuchal translucencySemantic proximity Read ↗

Prenatal Diagnostic Value of Chromosomal Microarray in Fetuses with Nuchal Translucency Greater than 2.5 mmSemantic proximity Read ↗

Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotypeSemantic proximity Read ↗

Genetic Examination for Fetuses with Increased Fetal Nuchal Translucency by Genomic TechnologySemantic proximity Read ↗

Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35Semantic proximity Read ↗

Combined Application of Chromosome Karyotype and Microarray Analysis in Fetus With Increased Nuchal TranslucencySemantic proximity Read ↗

Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort studySemantic proximity Read ↗

Chromosomal microarray in fetuses with increased nuchal translucencySemantic proximity Read ↗

Cut‐off value of nuchal translucency as indication for chromosomal microarray analysisSemantic proximity Read ↗

Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency: a French multicenter studySemantic proximity Read ↗

Diagnostic Value of Karyotyping, CMA/CNV-Seq, and WES in Fetuses with Thickened Nuchal Translucency: Perinatal and Two-Year Follow-Up OutcomesSemantic proximity Read ↗

Prenatal Diagnosis of Fetuses with Increased Nuchal Translucency by Genome Sequencing AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.